glp 1 agonists for diabetes GLP-1 Receptor Agonists: A Game-Changer Type 2 GLP-1 Agonists: A Comprehensive Overview
Description
Your GP or diabetes specialist will assess whether a GLP-1 receptor agonist is suitable based on NICE guidance, typically when metformin and other therapies have not achieved adequate control, or if you have a high BMI, cardiovascular disease, or chronic kidney disease
Both drugs have FDA boxed warnings for thyroid gland tumors, including cancer
The ECD was reported to be relatively dynamic even in the presence of hormone peptide
Some patients use GLP-1 medications indefinitely as a chronic disease management tool
doi: 10.1073/pnas.79.2.345 2 LundPKGoodmanRHHabenerJF
reviewed, edited and supervised the manuscript
